Outcome of Autologous Hematopoietic Stem Cell Transplantation in Refractory Multiple Myeloma

BACKGROUND: Despite the introduction of effective novel agents, the outcome of patients with refractory multiple myeloma remains poor, particularly those refractory to both proteasome inhibitors (PIs) and immunomodulatory agents (IMiDs). Limited data is available on the role of autologous hematopoie...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer
Autors principals: Veltri, Lauren W., Milton, Denái R., Delgado, Ruby, Shah, Nina, Patel, Krina, Nieto, Yago, Kebriaei, Partow, Popat, Uday R., Parmar, Simrit, Oran, Betul, Ciurea, Stefan, Hosing, Chitra, Lee, Hans C., Manasanch, Elisabet, Orlowski, Robert Z., Shpall, Elizabeth J., Champlin, Richard E., Qazilbash, Muzaffar H., Bashir, Qaiser
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5656242/
https://ncbi.nlm.nih.gov/pubmed/28513828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30770
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars